Short description
Innovate is a clinical stage biotechnology company developing novel medicines for gastroenterological and orphan disorders.
Description
Innovate, a privately held clinical stage biotechnology company, is focused on developing novel gastroenterology medicines. Their pipeline includes drug candidates for Celiac Disease and for mild to moderate ulcerative colitis, along with Secretin which improves pancreatic duct visualization in MRCP procedures. The Company is led by a strong management team with extensive business and regulatory experience. Innovate has all global rights to the products which are backed by more than 150 patents in the US, EU, and Japan.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Raleigh, North Carolina, United States, North America
Founded on
January 1, 2012
Exited on
July 8, 2016
Went public on
July 8, 2016
Stock symbol
INNT
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access
Sign in for full access
Founders
Jay Madan